Companies › Spyre Therapeutics
5 active drug programs in 6 registered trials: 5 Phase 2, 1 Phase 1; Immunology, Other; next expected readout Nov 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| SPY001 | – | Phase 2 | Ulcerative Colitis | Jun 2027 |
| SPY002 | – | Phase 2 | Ulcerative Colitis | Jun 2027 |
| SPY003 | – | Phase 2 | Ulcerative Colitis | Jun 2027 |
| SPY072 | – | Phase 2 | Hidradenitis Suppurativa (HS); Rheumatoid Arthritis | Oct 2027 |
| SPY003-207 | – | Phase 1 | Healthy | Nov 2026 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT06873724 | SPY003-207 | Phase 1 | Healthy | Other | Nov 2026 |
| NCT07012395 | SPY001 | Phase 2 | Ulcerative Colitis | Immunology | Jun 2027 |
| NCT07012395 | SPY002 | Phase 2 | Ulcerative Colitis | Immunology | Jun 2027 |
| NCT07012395 | SPY003 | Phase 2 | Ulcerative Colitis | Immunology | Jun 2027 |
| NCT07766005 | SPY072 | Phase 2 | Hidradenitis Suppurativa (HS) | Immunology | Oct 2027 |
| NCT07148414 | SPY072 | Phase 2 | Rheumatoid Arthritis | Immunology | Mar 2028 |
Cash and short-term investments of $1.1bn on 2026-09-30; operating cash outflow about $275m a year; runway about 48 months at that burn, to Sep 2030; 3 of 3 coming phase 2-3 readouts fall inside that runway
Press releases filed as 8-K in the last year:
Held by 15 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.
No annotated target.
–
Oruka Therapeutics Palisade Bio Sagimet Biosciences Aclaris Therapeutics Almirall
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.